FDA evaluating the risk of brain deposits with repeated use of gadolinium-based contrast agents for (MRI) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Monday, August 03, 2015

FDA evaluating the risk of brain deposits with repeated use of gadolinium-based contrast agents for (MRI)



Drug Safety Podcasts 

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.